Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Insignia Financial Ltd ( (AU:IFL) ) just unveiled an update.
Insignia Financial Ltd has announced a change in its substantial holding in Argenica Therapeutics Limited, indicating a shift in its investment strategy. The company has ceased to be a substantial holder as of July 16, 2025, following a series of transactions involving purchases and sales of shares through its subsidiaries, IOOF Investment Services Ltd and MLC Investments Ltd. This change may impact Insignia Financial’s market positioning and influence its stakeholders’ perceptions regarding its investment focus and strategy.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
More about Insignia Financial Ltd
Insignia Financial Ltd is a financial services company that operates in the investment management industry. It provides a range of financial products and services, including investment management and advisory services, primarily focusing on institutional and retail clients.
Average Trading Volume: 1,853,129
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$2.79B
For a thorough assessment of IFL stock, go to TipRanks’ Stock Analysis page.